Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 9.90 is 33% below its 5-year average of 14.73, near the low end of its 5-year range (7.69–25.41).
As of the fiscal period ended Tuesday, June 30, 2026. 24.69% below its 12-month average of 13.14.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.90.
QUICK RATIO (ACID-TEST)
9.90
QUICK RATIO (ACID-TEST) AVG TTM
13.14
QUICK RATIO (ACID-TEST) AVG 3Y
14.22
QUICK RATIO (ACID-TEST) AVG 5Y
14.73
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-24.69%
CURRENT VS 3Y AVG
-30.41%
CURRENT VS 5Y AVG
-32.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 849 covered companies
CURRENT VS SECTOR MEDIAN
+195.43%
vs the sector median at left
Pliant Therapeutics, Inc.
Market Cap
$63.16M
Quick Ratio (Acid-Test)
9.90
TTM Avg
13.14
3Y Avg
14.22
5Y Avg
14.73
Market Cap
$63.23M
Quick Ratio (Acid-Test)
0.27
TTM Avg
0.22
3Y Avg
0.21
5Y Avg
0.99
Market Cap
$63.41M
Quick Ratio (Acid-Test)
1.51
TTM Avg
1.60
3Y Avg
1.72
5Y Avg
2.07
Market Cap
$63.79M
Quick Ratio (Acid-Test)
0.97
TTM Avg
1.07
3Y Avg
1.19
5Y Avg
1.33
Market Cap
$64.43M
Quick Ratio (Acid-Test)
5.53
TTM Avg
4.01
3Y Avg
3.97
5Y Avg
5.62
Market Cap
$64.49M
Quick Ratio (Acid-Test)
0.53
TTM Avg
4.76
3Y Avg
5.20
5Y Avg
7.10
Market Cap
$61.44M
Quick Ratio (Acid-Test)
10.98
TTM Avg
17.43
3Y Avg
9.10
5Y Avg
12.08
Market Cap
$62.69M
Quick Ratio (Acid-Test)
3.15
TTM Avg
4.21
3Y Avg
4.66
5Y Avg
4.26
Market Cap
$60.49M
Quick Ratio (Acid-Test)
4.25
TTM Avg
2.40
3Y Avg
3.43
5Y Avg
5.08
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pliant Therapeutics, Inc. (PLRX) | $63.16M | 9.90 | 13.14 | 14.22 | 14.73 |
| Alps Group Inc (ALPS)vs › | $63.23M | 0.27 | 0.22 | 0.21 | 0.99 |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.41M | 1.51 | 1.60 | 1.72 | 2.07 |
| InterCure Ltd. (INCR)vs › | $63.79M | 0.97 | 1.07 | 1.19 | 1.33 |
| RenovoRx, Inc. (RNXT)vs › | $64.43M | 5.53 | 4.01 | 3.97 | 5.62 |
| Gossamer Bio, Inc. (GOSS)vs › | $64.49M | 0.53 | 4.76 | 5.20 | 7.10 |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.44M | 10.98 | 17.43 | 9.10 | 12.08 |
| Fractyl Health, Inc. (GUTS)vs › | $62.69M | 3.15 | 4.21 | 4.66 | 4.26 |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.49M | 4.25 | 2.40 | 3.43 | 5.08 |
| Cingulate Inc. (CING)vs › | $66.27M | 3.50 | 1.85 | 1.22 | 3.58 |
Quick Ratio
9.90
Excludes inventory
Current Ratio
9.90
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 9.90 |
| 2026-03-31 | 16.89 |
| 2025-12-31 | 12.00 |
| 2025-09-30 | 13.93 |
| 2025-06-30 | 12.99 |
| 2025-03-31 | 11.03 |
| 2024-12-31 | 10.91 |
| 2024-09-30 | 10.26 |
| 2024-06-30 | 14.47 |
| 2024-03-31 | 16.12 |
| 2023-12-31 | 17.72 |
| 2023-09-30 | 19.50 |
| 2023-06-30 | 19.16 |
| 2023-03-31 | 25.41 |
| 2022-12-31 | 14.23 |
| 2022-09-30 | 13.99 |
| 2022-06-30 | 7.69 |
| 2022-03-31 | 10.12 |
| 2021-12-31 | 12.44 |
| 2021-09-30 | 17.69 |
| 2021-06-30 | 22.93 |
| 2021-03-31 | 26.39 |
| 2020-12-31 | 25.07 |
| 2020-09-30 | 27.91 |
| 2020-06-30 | 26.95 |
| 2020-03-31 | 18.41 |
| 2019-12-31 | 13.69 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 6.20 |
| 2018-03-31 | 0.00 |
